NRG
MEDP icon

Nemes Rush Group’s Medpace MEDP Stock Holding History

Nemes Rush Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317K Buy
598
+27
+5% +$12.5K 0.03% 177
2026
Q1 		$274K Buy
571
+24
+4% +$12.3K 0.03% 186
2025
Q4 		$307K Sell
547
-95
-15% -$53.9K 0.03% 177
2025
Q3 		$330K Buy
642
+14
+2% +$6.11K 0.03% 156
2025
Q2 		$197K Buy
628
+48
+8% +$14.4K 0.02% 200
2025
Q1 		$177K Buy
580
+321
+124% +$108K 0.02% 213
2024
Q4 		$86K Buy
+259
New +$87.8K 0.01% 258
2024
Q3 		– Sell
-291
Closed -$120K – 631
2024
Q2 		$120K Buy
+291
New +$115K 0.02% 203

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Nemes Rush Group's MEDP Position: Q2 2026 in Review

Nemes Rush Group increased its Medpace (MEDP) stake by 4.7% in Q2 2026, buying an estimated $12.5K and bringing the position to 598 shares worth $317K. The position accounts for 0.03% of the portfolio, ranked #177.

Nemes Rush Group first reported a position in MEDP in Q2 2024 and has held it in 8 quarters since. The position peaked at $330K in Q3 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Nemes Rush Group held 598 shares of Medpace worth $317K as of Q2 2026.
  • Nemes Rush Group bought 27 Medpace shares in Q2 2026, an estimated $12.5K.
  • Medpace made up 0.03% of Nemes Rush Group's portfolio in Q2 2026, its #177 holding.
  • Nemes Rush Group first reported a position in Medpace in Q2 2024 and has held it in 8 quarters since.
  • Nemes Rush Group's Medpace position peaked at $330K in Q3 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.